Webinar to clarify EU HTAR processes for high risk medical devices and IVDs in June 2026

In May 2026, the EU Health Technology Assessment Regulation (HTAR) framework opened registration for a webinar scheduled for June 19, 2026. This event is targeted at manufacturers of high-risk medical devices and in vitro diagnostic medical devices (IVDs).

During the webinar, the Chairs and Co-chairs of the Member State Coordination Group on Health Technology Assessment (HTACG) and its subgroups will explain the processes for joint clinical assessments (JCA) and joint scientific consultations (JSC) for these devices. They will also discuss key guidance documents that have been adopted by HTACG to support these processes.

Additionally, the HTA Secretariat of the European Commission will provide detailed insights into the administrative and IT processes involved, including instructions on how to access and utilize the HTA IT Platform for JSC and JCA workflows.

See the full details here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.